Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient

Artículo original

Año: 2025

Alarcón-Payer, C; Suárez, MDS; Roldán, AM; Morales, AJ

Título: ANTI-CANCER DRUGS

• Q3